Oregon Prescription Drug Monitoring Program

CEO Bryan Boehringer is working with a statewide coalition to reduce opioid abuse, while Rep. Knute Buehler is introducing legislation next month.

Sen. Alan Bates asked the Democratic leadership to pull his own bill modifying the prescription drug monitoring program after he discovered that SB 626 allowed county health officials and state epidemiologists to receive personally identifiable information.

Rep. Mitch Greenlick opposes allowing the Board of Pharmacy to add drugs to the tracking system that are not controlled by the DEA, aligning his concerns with the American Civil Liberties Union.